Login to Your Account



Financings Roundup

Blaze Bioscience Raises $5M in Series A for Tumor Paint

By Marie Powers
Staff Writer

Wednesday, August 8, 2012

Less than two years after its founding and 10 months after licensing its technology from Seattle's Fred Hutchinson Cancer Research Center, privately held Blaze Bioscience Inc. raised $5 million in a Series A financing.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription